2023 Form 5500 filing — Leading Pharma 401(K) Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241002135307NAL0004845923001) for Leading Pharma 401(K) Plan, reported by Leading Pharma, LLC under EIN 47-1297885 and plan number 001. It reports 221 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).
- EFAST2 acknowledgement
- 20241002135307NAL0004845923001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- Leading Pharma, LLC
- EIN
- 47-1297885
- Plan number
- 001
- Location
- Fairfield, NJ
- Participants
- 221
- Schedules available
- Schedule H, Schedule C
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
- Total assets (EOY)
- $4,957,143
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $4,957,143
- Employer contributions
- $310,836
- Participant contributions
- $616,667
- Total income / additions
- $1,639,871
- Benefits paid
- $408,501
- Administrative expenses
- $30,204
- Total expenses
- $438,705
- Net increase / (decrease)
- $1,201,166
- Schedule source
- Schedule H
Reported service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. |
|---|---|---|---|
| Nationwide Life Insurance Co | INVESTMENTS RECORDKEEPER | $63,816 | $5,738 |
| Securian Financial Services In | INVESTMENTS | $0 | $17,728 |
| Stadion Money Management, LLC | INVESTMENTS | $14,918 | not reported in the loaded dataset |
| Cetera Advisor Networks LLC | INVESTMENTS | $0 | $6,634 |
| Iron-Co-Fid-Comprehensive | INVESTMENTS | $5,438 | not reported in the loaded dataset |
| Planned Financial Programs | THIRD PARTY ADMINISTRATO | $5,045 | not reported in the loaded dataset |